Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2/3 1

Status

Recruiting 3Active not recruiting 3

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Head & Neck 6

Conditions

Squamous Cell Carcinoma of Head and Neck 10Nasopharyngeal Carcinoma 6Prostatic Neoplasms 5Oropharyngeal Neoplasms 4Laryngeal Neoplasms 3Carcinoma 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Rectal Neoplasms 2Mouth Neoplasms 2Mesothelioma 2Hypopharyngeal Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Astrocytoma 2Vaginal Neoplasms 1Urothelial Carcinoma of the Bladder 1Tongue Neoplasms 1Sarcoma 1Salivary Gland Neoplasms 1PSA Level Greater Than Two 1Oligodendroglioma 1Mesothelioma, Malignant 1Meningioma 1Lymphoma, Follicular 1Lymphoid Interstitial Pneumonia 1Lung Neoplasms 1Locally Advanced Cervical Adenocarcinoma 1HIV Infections 1Glioma 1

Interventions

Cisplatin 12Gemcitabine 9Specimen Handling 6Radiotherapy, Intensity-Modulated 6Magnetic Resonance Spectroscopy 6Drug Therapy 5toripalimab 4Platinum 4Nivolumab 4Capecitabine 41,2-diaminocyclohexaneplatinum II citrate 4spartalizumab 3Radiotherapy 3Immune Checkpoint Inhibitors 3sintilimab 2Ipilimumab 2Immunoglobulin G 2Docetaxel 2Disulfides 2Carboplatin 2CTLA-4 Antigen 2Biopsy 2tislelizumab 1relatlimab 1pembrolizumab 1olaparib 1fluciclovine F-18 1dehydroftorafur 1cemiplimab 1camrelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Nasopharyngeal Carcinoma × Radiotherapy, Intensity-Modulated × 30 days × Clear all
NCT05145660 2026-05-28

Optimization of Cervical Nodal CTV for Early and Medium Stage NPC

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 3 Active not recruiting
414 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT04436965 2026-05-11

Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition

Sun Yat-sen University

Phase 3 Recruiting
266 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT05340491 2026-05-11

Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial

Sun Yat-sen University

Phase 3 Recruiting
212 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT05780372 2026-05-11

Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 3 Active not recruiting
474 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT05941741 2026-05-11

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Sun Yat-sen University

Phase 3 Recruiting
380 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT02135042 2026-05-07

Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

NRG Oncology

Phase 2/3 Active not recruiting
685 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡